3.18
+11.19%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sensus Healthcare
From its filings with the US Securities and Exchange Commission
Sensus Healthcare is based in Boca Raton, Florida and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker SRTS. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $27.5m and a net loss of $7.7m. At that date it held total assets of $53.0m and shareholders' equity of $48.1m. By business, Product [Member] brought in 71.9% of revenue, followed by Service Revenue [Member] at 12.6% and Service [Member] at 9.2%. By region, UNITED STATES accounted for 92.3%, followed by CHINA at 7.4% and Other [Member] at 0.3%.
As of December 31, 2025, the Company had installed 955 units in 21 countries, primarily in the United States.
High reliability and MTBF (“mean time between failures”) performance that provides availability for patients and practitioners and lowers the total cost of ownership.
U.S., the Company believes its SRT products offer a simpler, faster method of treatment with a better overall patient experience.
The Company also relies on trademarks to enhance, build, and maintain the integrity of the Sensus brand.
U.S. For Class II devices, 510(k) is the most common pathway to obtain market authorization in the US.
Class III, or de novo) have not been appropriate for our developed products and may involve extended review periods.
Reports of Corrections and Removals regulation, which requires that manufacturers and importers (a) report to the FDA recalls (i.e., corrections or removals) if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health, and (b) keep records of recalls that they determine to be not reportable, all in accordance with 21 CFR, Part 806.
Quoted from its 10-K, filed 4 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 3 Jun 2016
- Employees
- 60
- Website
- sensushealthcare.com ↗
- Head office
- 851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL, 33487
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Joseph SardanoChairman of the Board, Chief Executive Officer, Co-Founder, since 2010$1.3m
- Mr. Michael SardanoPresident, General Counsel, Corporate Secretary, Chief Commercial Officer, Director, since 2017$1.3m
- Mr. Javier RampollaChief Financial Officer$656,045
- Ms. Magdalena MartinezChief Operating Officer
- Mr. Emiliano SosaChief Technology Officer
- Mr. Larry BiscottiDirector
- Mr. Eric SachettaIndependent Director
- Ms. Megan CornishNon-Employee Independent Director$235,600
- Mr. Anthony PetrelliNon-Employee Independent Director$235,600
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Advanced Technology: Sensus Healthcare Inc benefits from its state-of-the-art technology, allowing it to offer innovative and effective medical devices for skin cancer treatment.
- Strong Market Position: With a well-established presence in the healthcare industry, Sensus Healthcare Inc has achieved a significant market share and brand recognition in the dermatology field.
- Experienced Management Team: The company is led by a skilled and knowledgeable management team with extensive expertise in the medical device sector, contributing to effective decision-making and strategic planning.
Weaknesses
- Limited Product Portfolio: Sensus Healthcare Inc primarily focuses on skin cancer treatment devices, which may limit its revenue potential compared to companies with diversified product offerings.
- Dependence on Healthcare Regulations: Changes or tightening of healthcare regulations can impact the company's ability to operate or market its products effectively, potentially causing disruptions in its business operations.
- Relatively Small Scale: Compared to larger competitors, Sensus Healthcare Inc's smaller size and resources may restrict its ability to invest extensively in research and development, limiting its ability to introduce new products or expand into new markets.
Opportunities
- Growing Demand for Skin Cancer Treatment: The increasing prevalence of skin cancer and rising awareness among individuals about early diagnosis and treatment provide an opportunity for Sensus Healthcare Inc to capitalize on a growing market.
- International Expansion: Exploring new markets beyond its current geographic reach could enable Sensus Healthcare Inc to diversify its customer base and increase revenue streams.
- Collaborations and Partnerships: Forming strategic partnerships with dermatology clinics, hospitals, and research institutions can bring about synergies, enhance product development, and facilitate market penetration.
Threats
- Intense Competition: Sensus Healthcare Inc faces competition from larger medical device companies as well as emerging startups, which could potentially erode its market share or pressure its pricing strategy.
- Regulatory Challenges: Changes in government regulations, compliance requirements, and obtaining necessary approvals may pose challenges for Sensus Healthcare Inc, impacting its ability to bring new products to market in a timely manner.
- Economic Volatility: Unpredictable economic conditions, such as a recession or financial crisis, can affect consumer spending and healthcare budgets, potentially reducing demand for Sensus Healthcare Inc's products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.